Takeda's Vedolizumab Demonstrated Robust Clinical Effectiveness and Safety in Inflammatory Bowel Disease in More Than 50 RealWorld Studies

OSAKA Japan Oct. 17 2016 PRNewswire Takeda Pharmaceutical Company Limited TSE 4502 "Takeda" is presenting data on the realworld effectiveness and safety of vedolizumab in patients with moderately to severely active ulcerative colitis UC and Croh...